Pro-Pharmaceuticals, Inc. (PRWP.OB) Announces Collaboration with Numoda to Increase DAVANAT’s Speed-to-Market
Pro-Pharmaceuticals, Inc. is engaged in the discovery, development and commercialization of therapeutics that target Galectin receptors for the advanced treatment…